<DOC>
	<DOCNO>NCT02127749</DOCNO>
	<brief_summary>The purpose study determine whether treatment antibiotic , harm gut flora , cause immune system less effective .</brief_summary>
	<brief_title>The Role Gut Microbiota Systemic Immune Response During Human Endotoxemia</brief_title>
	<detailed_description>Rationale : Sepsis rank among top ten lead cause death worldwide . Most nonsurvivors die state immunosuppression . The gut microbiota exert numerous beneficial function host response infection . Gut flora component express microorganism-associated molecular pattern ( MAMPs ) lipopolysaccharide ( LPS ) , recognize pattern recognition receptor ( PRRs ) express neutrophils macrophage . MAMPs intestinal microbiota constitutively translocate circulation prime bone marrow derive neutrophil via PRRs . Antibiotic treatment , standard care patient sepsis , deplete gut microbiota lead diminished release MAMPs bacteria derive product . This cause diminished prim systemic immunity , may attribute sepsis associate immunosuppression increase susceptibility invade bacteria . Objective : To investigate role gut microbiota systemic priming immune effector cell human endotoxemia Study design : Randomized , between- within-subject-controlled intervention study human volunteer Intervention : All subject receive lipopolysaccharide ( endotoxin ; 2 ng/kg bodyweight ) intravenously induce experimental endotoxemia . Eight subject pretreated broad spectrum antibiotic ( ciprofloxacin , vancomycin , metronidazole ) seven day ( washout period 36 hour endotoxemia ) , order deplete gut microbiota . Blood faeces sample , endotoxemia .</detailed_description>
	<mesh_term>Endotoxemia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Ciprofloxacin</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Healthy Male 18 35 year age Capable give write informed consent Chemistry panel without clinically relevant abnormality Normal defecation pattern Major illness past 3 month chronic medical illness History type malignancy Past current gastrointestinal disease Known positive test hepatitis C antibody , hepatitis B surface antigen HIV antibody 1 2 Current chronic history liver disease Subject use tobacco product History , within 3 year , drug abuse History alcoholism Any clinically relevant abnormality 12lead ECG The subject receive investigational product within three month Use prescription nonprescription drug Use antibiotic within 12 month Known allergy antibiotic Subject difficultly donate blood accessibility vein leave right arm . Subject donate 350 mL blood last 3 month Difficulty swallow pill Body mass index 28</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>antibiotic</keyword>
	<keyword>gut microbiota</keyword>
	<keyword>endotoxemia</keyword>
	<keyword>innate immunity</keyword>
</DOC>